Related Experiment Videos
European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation
S.L.A.M. Bronzwaer1, W Goettsch, B Olsson-Liljequist
1National Institute of Public health and the Environment, Bilthoven, Pays-Bas.
Abstract:
Effective European surveillance must have the agreement and active involvement of all participants, concluded a European Union (EU) conference on the need for surveillance of resistant microorganisms (the microbial threat), held in September 1998 in De
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Implementing managed entry agreements in practice: The Dutch reality check.
Health policy (Amsterdam, Netherlands)·2018
Report on the first PVL-positive community acquired MRSA strain in Latvia.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making.
Clinical pharmacology and therapeutics·2016
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.
Clinical pharmacology and therapeutics·2015
Increased gene expression of the cardiac endothelin system in obese mice.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Thirty years of an advanced field epidemiology training programme: a mixed-methods evaluation, Germany, 1996 to 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Elimination of congenital syphilis: a nationwide register-based study, Denmark, 2010 to 2024.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Detection of nirsevimab-resistant RSV-B variants in children carrying the F:N201T substitution through genomic surveillance, Spain, 2025/26 season.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
First year of ongoing invasive Haemophilus influenzae type b outbreak among middle-aged people who use drugs and people who experience homelessness in Hamburg, Germany, September 2024 to August 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Emerging trends in invasive Streptococcus dysgalactiae subsp. equisimilis infections in Denmark, 2014 to 2024: a nationwide genomic and registry-based study.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin for Neisseria gonorrhoeae from antimicrobial resistance sentinel surveillance, Germany, 2014 to 2023.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
A Dataset of Psychiatric Hospital Notes with Temporal Information Annotations.
LREC ... International Conference on Language Resources & Evaluation : [proceedings]. International Conference on Language Resources & Evaluation·2026
Clustering of self-reported social and environmental risk factors identifies vulnerable subgroups with increased asthma morbidity.
The journal of allergy and clinical immunology. Global·2026
Mapping one health surveillance and networks for vector-borne disease prevention and control in Europe - A scoping review.
One health (Amsterdam, Netherlands)·2026
Histoplasma Capsulatum Antigen Persistence and Rate of Decay During Treatment of Histoplasmosis Varies by Immune Status.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Diagnostic accuracy of the VISITECT CD4 lateral-flow assay for screening advanced HIV disease: a systematic review and meta-analysis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026